NCT00890721已完成3 期
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Single Administration of SKY0402 for Prolonged Postoperative Analgesia in Subjects Undergoing Hemorrhoidectomy
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 189
- 试验地点
- 1
- 主要终点
- The Area Under the Curve (AUC) of the Numeric Rating Scale at Rest (NRS-R) Pain Intensity Scores Through 72 Hours for Subjects Receiving SKY0402 vs. Placebo.
研究概览
简要总结
Patients will get an injection of either SKY0402 or placebo during hemorrhoid surgery, and their pain and pain medicine use will be monitored.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age > 18 years of age at the Screening visit
- •American Society of Anesthesiologists (ASA) class 1-3
- •Scheduled to have a two or three column excisional hemorrhoidectomy under general anesthesia using the Milligan-Morgan technique
- •For female subjects, surgically sterile or at least two years menopausal, or using an acceptable method of birth control; must have a documented negative blood or urine pregnancy test within 24 hours before surgery
- •Clinical lab values less than or equal to twice the upper limit of normal or, if abnormal, deemed not clinically significant per the Investigator.
- •Ability to understand the requirements of the study, provide written informed consent, abide by the study restrictions, and agree to return for the required assessments
- •Able to speak, read, and understand the language of all subject-facing documents, including the ICF and study questionnaires
- •Able and willing to comply with all study visits and procedures
排除标准
- •Single-column hemorrhoidectomy or hemorrhoidectomy without an internal component
- •Body weight less than 50 kilograms (110 pounds)
- •History of hypersensitivity or idiosyncratic reactions or amide-type local anesthetics, opioids, or propofol
- •Current painful physical condition or concurrent surgery other than hemorrhoids that may require analgesic treatment (such as non-steroidal anti-inflammatory drug [NSAID], opioid, selective serotonin reuptake inhibitor [SSRI], tricyclic antidepressant, gabapentin, pregabalin) in the postoperative period for pain that is not strictly related to the hemorrhoidectomy procedure and may confound the postoperative assessments
- •Concurrent fissurectomy
- •Use of any NSAID including selective COX-2 inhibitor, opioid, SSRI, tricyclic antidepressant, gabapentin, or pregabalin within three days of surgery
- •Use of acetaminophen within 24 hours of surgery
- •Chronic users of analgesic medications, including taking opioid medications for more than 14 days in the last 3 months, or non-opioid pain medications more than 5 times per week
- •History of, suspected, or known addiction to or abuse of drugs or alcohol within the past two years
- •Current use of glucocorticosteroids or use of glucocorticoids within one month of enrollment into this study
- •HIV infection or hepatitis
- •Currently pregnant, nursing, or planning to become pregnant during the course of the study or within one month of study drug administration
- •Any psychiatric, psychological, medical, or laboratory condition that the investigator feels makes the subject an inappropriate candidate for this clinical trial
- •Subjects who have received another investigational drug within the longer of the last 30 days or 10 elimination half-lives
- •Previous participation in a SKY0402 study
- •Failure to pass drug and alcohol screen
研究组 & 干预措施
SKY0402
Experimental
During the hemorrhoidectomy, 30cc of SKY0402 is injected into the wound.
干预措施: SKY0402 (Drug)
Placebo
Placebo Comparator
During the hemorrhoidectomy, 30cc Placebo injected into the wound.
干预措施: Placebo (Drug)
结局指标
主要结局
The Area Under the Curve (AUC) of the Numeric Rating Scale at Rest (NRS-R) Pain Intensity Scores Through 72 Hours for Subjects Receiving SKY0402 vs. Placebo.
时间窗: 72 hours
To assess pain intensity at rest (NRS-R), the subject was to assume a resting position that did not exacerbate his or her postoperative pain and respond to the following question: "On a scale of 0 to 10, where 0 = no pain and 10 = worst possible pain, how much pain are you having right now?"
次要结局
- Participants With Adverse Events Through 72 Hours or Serious Adverse Events Through 30 Days(30 days)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
RCT of Mushroom Based Natural Product to Enhance Immune Response to COVID-19 VaccinationCOVID-19 VaccinationNCT04951336University of California, San Diego90
已完成
2 期
EC-18 for Oral Mucositis in Patients With Concomitant ChemoirradiationStomatitisNCT03200340Enzychem Lifesciences Corporation105
已完成
2 期
Treatment for Subjects With Unresectable Stage III or Stage IV MelanomaCancerMelanomaNCT00110994Bayer101
Unknown
1 期
Use of Intranasal Oxytocin During Detoxification of Crack CocaineCocaine WithdrawalCocaine SmokingCocaine-Related DisordersNCT04306354Pontificia Universidade Católica do Rio Grande do Sul96
已完成
2 期
A Phase II Study of HY209 Gel for Atopic Dermatitis Patients (Shaperon)Atopic DermatitisNCT04530643Shaperon80